Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,765,282
-$4,244,763 QoQ
Shares Held
22,315
-33.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.53%
of 13F equity value
Holder Rank
#763
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. LLY ranks #3 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
151,500 | $28,727,430 | |
| 2 | MRK |
Merck & Co., Inc.
|
213,500 | $27,434,750 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
22,315 | $26,765,282 | |
| 4 | ABBV |
AbbVie Inc.
|
96,775 | $24,352,461 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
178,250 | $22,520,105 | |
| 6 | BIIB |
Biogen Inc.
|
94,850 | $20,493,291 | |
| 7 | JNJ |
Johnson & Johnson
|
72,500 | $18,412,825 | |
| 8 | AMGN |
Amgen Inc
|
11,900 | $4,309,228 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,765,282 | 22,315 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $31,010,045 | 33,715 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $45,372,993 | 42,220 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $40,759,460 | 53,420 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $45,111,401 | 57,870 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $34,481,742 | 41,750 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $35,087,400 | 45,450 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $42,082,150 | 47,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $42,552,860 | 47,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $42,145,983 | 54,175 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $45,470,674 | 78,005 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $53,713,000 | 100,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $37,987,380 | 81,000 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $32,193,920 | 88,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $31,364,950 | 97,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,180,700 | 90,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $35,366,695 | 123,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $46,957,400 | 170,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $33,502,250 | 145,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,266,976 | 118,800 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $31,759,400 | 170,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $30,391,200 | 180,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $24,423,300 | 165,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $17,238,900 | 105,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $13,872,000 | 100,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||